# A Trial of GH001 in Patients With Treatment-resistant Depression

> **NCT05800860** · PHASE2 · COMPLETED · sponsor: **GH Research Ireland Limited** · enrollment: 81 (actual)

## Conditions studied

- Treatment-resistant Depression

## Interventions

- **DRUG:** GH001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05800860
- **Lead sponsor:** GH Research Ireland Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-24
- **Primary completion:** 2024-10-04
- **Final completion:** 2025-03-11
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2025-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05800860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05800860, "A Trial of GH001 in Patients With Treatment-resistant Depression". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05800860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*